Drug Profile
Research programme: PPAR agonists - Genfit
Alternative Names: Compound 18; G 200; G120; G150; G170; GFT120Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Genfit
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Diabetes mellitus; Dyslipidaemias; Hypertension; Obesity
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Atherosclerosis in France
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in France
- 04 Nov 2017 No recent reports of development identified for preclinical development in Dyslipidaemias in France